Related Experiment Video
Updated: Jul 13, 2026

The Examination of Peroxidase-Positive Leukocytes in Semen
Published on: January 19, 2024
Myeloperoxidase binds to non-vital spermatozoa on phosphatidylserine epitopes
Jacqueline Lessig1, Holger Spalteholz, Uta Reibetanz
1Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstr. 16-18, 04107, Leipzig, Germany, juergen.arnhold@medizin.uni-leipzig.de.
Abstract:
The heme protein myeloperoxidase is released from stimulated polymorphonuclear leukocytes, a cell species found in increasing amounts in the male and female genital tract of patients with genital tract inflammations. Myeloperoxidase binds only to a fraction of freshly prepared human spermatozoa. The number of spermatozoa able to bind myeloperoxidase raised considerably in samples containing pre-damaged cells or in acrosome-reacted samples. In addition, myeloperoxidase released from zymosan-stimulated polymorphonuclear leukocytes was also able to bind to pre-damaged spermatozoa. The ability of spermatozoa to bind myeloperoxidase coincided with the binding of annexin V to externalized phosphatidylserine epitopes indicating the loss of plasma membrane integrity and with the incorporation of ethidium homodimer I. Myeloperoxidase did not interact with intact spermatozoa. Annexin V and myeloperoxidase bind to the same binding sites as verified by double fluorescence techniques, flowcytometry analyses as well as competition experiments. We demonstrated also that myeloperoxidase is eluted together with pure phosphatidylserine liposomes or liposomes composed of phosphatidylserine and phosphatidylcholine in gel filtration, but not with pure phosphatidylcholine liposomes. In conclusion, myeloperoxidase interacts with apoptotic spermatozoa via binding to externalized phosphatidylserine indicating a yet unknown role of this protein in recognition and removal of apoptotic cells during inflammation.
Insights
Myeloperoxidase (MPO) binds to apoptotic human spermatozoa, specifically to externalized phosphatidylserine. This suggests MPO plays a role in clearing damaged sperm cells during inflammation.
Area of Science:
- Reproductive immunology
- Cellular biology
- Inflammation research
Background:
- Polymorphonuclear leukocytes (PMNs) release myeloperoxidase (MPO) during inflammation.
- Increased PMNs and MPO are found in the genital tracts of patients with inflammation.
- MPO's interaction with spermatozoa in this context is not well understood.
Purpose of the Study:
- To investigate the binding of MPO to human spermatozoa.
- To determine the characteristics of spermatozoa that bind MPO.
- To elucidate the mechanism and binding sites of MPO-spermatozoa interaction.
Main Methods:
- Flow cytometry analysis of MPO and annexin V binding to spermatozoa.
- Assessment of sperm viability using ethidium homodimer I.
- Competition experiments and gel filtration with liposomes to identify MPO binding sites.
Main Results:
- MPO binds to a fraction of human spermatozoa, particularly pre-damaged or acrosome-reacted cells.
- MPO binding correlates with externalized phosphatidylserine (indicating loss of membrane integrity) and ethidium homodimer I incorporation.
- MPO and annexin V share common binding sites on spermatozoa, and MPO interacts with phosphatidylserine.
Conclusions:
- Myeloperoxidase interacts with apoptotic human spermatozoa by binding to externalized phosphatidylserine.
- This interaction suggests a novel role for MPO in the recognition and clearance of apoptotic sperm cells during genital tract inflammation.
Related Concept Videos
Spermatogenesis
Sperm Structure and Semen Composition

